Intervention Mechanism and Safety of Compound Qima Capsule on Carotid Atherosclerosis Plaques

LIANG Wen-jian; WANG Qing-hai

doi:10.13422/j.cnki.syfjx.20181819

您当前的位置：

首页 >

文章列表页 >

Intervention Mechanism and Safety of Compound Qima Capsule on Carotid Atherosclerosis Plaques

更新时间：2024-01-04

- Intervention Mechanism and Safety of Compound Qima Capsule on Carotid Atherosclerosis Plaques
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 19, Pages: 189-194(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20181819
  CLC： R259
- Published：2018
- 稿件说明：
移动端阅览
LIANG Wen-jian, WANG Qing-hai. Intervention Mechanism and Safety of Compound Qima Capsule on Carotid Atherosclerosis Plaques[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(19): 189-194.
DOI：

LIANG Wen-jian, WANG Qing-hai. Intervention Mechanism and Safety of Compound Qima Capsule on Carotid Atherosclerosis Plaques[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(19): 189-194. DOI： 10.13422/j.cnki.syfjx.20181819.

摘要

目的：通过观察复方芪麻胶囊治疗颈动脉粥样硬化斑块的临床效果，探求其干预作用机制及安全性。方法：将80例颈动脉粥样硬化患者随机分为对照组和观察组，各40例。两组均给予阿托伐他汀钙片口服，观察组加用复方芪麻胶囊口服，共治疗6个月。比较两组治疗前后各项指标的变化以评估疗效；检测治疗前后双侧颈动脉内膜-中层厚度（IMT）和颈动脉斑块面积；检测治疗前后甘油三酯（TG），总胆固醇（TC），高密度脂蛋白胆固醇（HDL-C）和低密度脂蛋白胆固醇（LDL-C）水平；检测治疗前后血清炎症因子白细胞介素-6（IL-6），肿瘤坏死因子-α（TNF-α），基质金属蛋白酶-9（MMP-9）水平；检测治疗前后血管内皮损伤指标一氧化氮（NO），内皮素-1（ET-1），6-酮前列腺素F1α（6-Reto-PGF1α）水平；以及不良反应情况。结果：治疗后，观察组的总有效率为95.00%，显著高于对照组的82.50%（P<0.05）。与对照组比较，观察组双侧颈动脉斑块面积和IMT明显降低，治疗后的血脂水平（TC，TG，LDL-C）明显降低（P<0.05）；血管内皮功能明显改善（P<0.05）；炎症因子明显降低（P<0.05）。两组患者治疗期间均无不良反应发生。结论：经过复方芪麻胶囊干预治疗颈动脉粥样硬化，颈动脉斑块面积显著缩小，IMT明显变薄，引起或加重颈动脉粥样硬化的各项实验室指标均明显改善；推测复方芪麻胶囊可能是通过降脂、抑制炎症反应、改善血管内皮功能等机制干预颈动脉粥样硬化斑块；其安全性良好。

Abstract

Objective: To explore the intervention mechanism and safety of compound Qima capsule in the treatment of carotid atherosclerosis plaques by observing its clinical efficacy. Method: Eighty patients with carotid atherosclerosis plaques were randomly divided into control group and treatment group (40 cases in each group). Patients in control group were treated with atorvastatin calcium tablets for 6 months. Patients in treatment group were additionally treated with compound Qima capsule for 6 months. The changes in the indicators were compared and the efficacy was assessed in both groups. Before and after treatment

thickness of carotid intima of the carotidartery (IMT) and atherosclerotic plaque area were detected by color Doppler ultrasound; levels of triglycerides (TG)

total cholesterol (TC)

high density lipoprotein-C (HDL-C) and low density lipoprotein-C (LDL-C) were detected; level of nitric oxide(NO)

endothelin-1(ET-1) and 6-ketone prostaglandin F1 α (6-Reto-PGF1α) were detected. Levels of interleukin-6 (IL-6)

tumor necrosis factor-α(TNF-α)

and matrix metalloproteinases-9 (MMP-9) were also detected.In addition

adverse drug reactions were compared between two groups. Result: After treatment

the total effective rate in treatment group was significantly higher than that in control group (P<0.05). By comparison with control group

the blood lipid levels and inflammatory factors in treatment group were significantly reduced (P<0.05)

vascular endothelial function was significantly improved (P<0.05)

bilateral carotid plaque area and carotid intima-media thickness were significantly reduced after treatment (P<0.05). There were no adverse drug reactions in both groups during the treatment. Conclusion: Compound Qima capsule can significantly decrease the bilateral carotid plaque area and carotid intima-media thickness

and improve the symptoms of carotid atherosclerosis with high safety for patients with carotid atherosclerosis plaques

and the mechanism may be related to regulating lipid metabolism

improving the endothelial function and anti-inflammatory response.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Zhuyuwan in Treatment of Hyperlipidemia Complicated with Carotid Atherosclerosis： A Randomized Controlled Trial

Bayesian Network Meta-analysis of Therapeutic Effect of Oral Chinese Patent Medicines on Coronary Artery Disease Complicated with Carotid Atherosclerosis

Effect of Huatan Tongluo Prescription on Vulnerability of Carotid Atherosclerotic Plaque in Hypertension

Quercetin Against Cerebral Ischemia-reperfusion Injury： A Review

Modern Research of Nasal Preparations of Traditional Chinese Medicine： A Review

Related Author

SHEN Tao

ZHANG Zhongyi

YANG Lele

SONG Wei

QU Chao

YU Jiaxiang

ZHANG Hanwen

WANG Lie

Related Institution

Hospital of Chengdu University of TCM

Chengdu University of Traditional Chinese Medicine（TCM）

The Second Affiliated Hospital of Liaoning University of TCM/Liaoning Academy of TCM

Liaoning University of Traditional Chinese Medicine（TCM）

Jinan Vocational College of Nursing

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰